• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更进一步:为何囊性纤维化的临床研究必须纳入儿童。

Going the Extra Mile: Why Clinical Research in Cystic Fibrosis Must Include Children.

作者信息

Dobra Rebecca, Bentley Siân, Edmondson Claire, Ovens Maxine, Saunders Clare, Short Christopher, Wilson Gemma, Davies Jane C, Bush Andrew

机构信息

National Heart and Lung Institute, Imperial College, London SW3 6LY, UK.

Paediatric Respiratory Medicine Department, Royal Brompton Hospital, London SW3 6NP, UK.

出版信息

Children (Basel). 2022 Jul 20;9(7):1080. doi: 10.3390/children9071080.

DOI:10.3390/children9071080
PMID:35884064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9323167/
Abstract

This is an exciting time for research and novel drug development in cystic fibrosis. However, rarely has the adage, "Children are not just little adults" been more relevant. This article is divided into two main sections. In the first, we explore why it is important to involve children in research. We discuss the potential benefits of understanding a disease and its treatment in children, and we highlight that children have the same legal and ethical right to evidence-based therapy as adults. Additionally, we discuss why extrapolation from adults may be inappropriate, for example, medication pharmacokinetics may be different in children, and there may be unpredictable adverse effects. In the second part, we discuss how to involve children and their families in research. We outline the importance and the complexities of selecting appropriate outcome measures, and we discuss the role co-design may have in improving the involvement of children. We highlight the importance of appropriate staffing and resourcing, and we outline some of the common challenges and possible solutions, including practical tips on obtaining consent/assent in children and adolescents. We conclude that it is unethical to simply rely on extrapolation from adult studies because research in young children is challenging and that research should be seen as a normal part of the paediatric therapeutic journey.

摘要

对于囊性纤维化的研究和新型药物开发而言,这是一个激动人心的时代。然而,“儿童并非小大人”这句格言从未像现在这样贴切。本文分为两个主要部分。第一部分,我们探讨让儿童参与研究为何重要。我们讨论了解儿童疾病及其治疗方法的潜在益处,并强调儿童与成人一样拥有接受循证治疗的同等法律和道德权利。此外,我们还讨论了为何从成人研究推断可能并不合适,例如儿童的药物药代动力学可能不同,而且可能会出现不可预测的不良反应。在第二部分,我们讨论如何让儿童及其家庭参与研究。我们概述了选择合适结局指标的重要性和复杂性,并讨论了共同设计在提高儿童参与度方面可能发挥的作用。我们强调了配备合适人员和资源的重要性,并概述了一些常见挑战及可能的解决方案,包括获取儿童和青少年同意/赞成的实用技巧。我们得出结论,仅仅依靠成人研究推断是不道德的,因为幼儿研究具有挑战性,而且研究应被视为儿科治疗过程的正常组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26e/9323167/aea9f8def2ff/children-09-01080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26e/9323167/aea9f8def2ff/children-09-01080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26e/9323167/aea9f8def2ff/children-09-01080-g001.jpg

相似文献

1
Going the Extra Mile: Why Clinical Research in Cystic Fibrosis Must Include Children.更进一步:为何囊性纤维化的临床研究必须纳入儿童。
Children (Basel). 2022 Jul 20;9(7):1080. doi: 10.3390/children9071080.
2
How should assent to research be sought in low income settings? Perspectives from parents and children in Southern Malawi.在低收入环境中,应该如何寻求对研究的同意?来自马拉维南部的父母和孩子的观点。
BMC Med Ethics. 2019 May 14;20(1):32. doi: 10.1186/s12910-019-0369-7.
3
Challenges for consent and community engagement in the conduct of cluster randomized trial among school children in low income settings: experiences from Kenya.在低收入环境下对在校儿童进行整群随机试验中,同意和社区参与的挑战:肯尼亚的经验。
Trials. 2013 May 16;14:142. doi: 10.1186/1745-6215-14-142.
4
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.《2018年炎症性肠病在加拿大的影响:患有炎症性肠病的儿童和青少年》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.
5
Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis.是时候认真对待囊性纤维化早期肺病的检测和监测了。
Thorax. 2021 Dec;76(12):1255-1265. doi: 10.1136/thoraxjnl-2020-216085. Epub 2021 Apr 29.
6
Consent and assent in paediatric research in low-income settings.低收入环境下儿科研究中的同意与赞成。
BMC Med Ethics. 2014 Mar 5;15:22. doi: 10.1186/1472-6939-15-22.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Industry and Patient Perspectives on Child Participation in Clinical Trials: The Pediatric Assent Initiative Survey Report.行业与患者对儿童参与临床试验的看法:儿科同意倡议调查报告。
Ther Innov Regul Sci. 2018 Jan;52(1):29-37. doi: 10.1177/2168479017716490. Epub 2017 Jun 30.
9
Informed consent instead of assent is appropriate in children from the age of twelve: Policy implications of new findings on children's competence to consent to clinical research.对于12岁及以上儿童,适用知情同意而非同意:关于儿童同意参与临床研究能力的新发现的政策影响。
BMC Med Ethics. 2015 Nov 9;16(1):76. doi: 10.1186/s12910-015-0067-z.
10

引用本文的文献

1
Advances in the pathogenesis and personalised treatment of paediatric asthma.儿童哮喘的发病机制与个性化治疗进展
BMJ Med. 2023 Jun 25;2(1):e000367. doi: 10.1136/bmjmed-2022-000367. eCollection 2023.
2
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis.类器官技术及其在囊性纤维化治疗分型应用中的作用。
Children (Basel). 2022 Dec 20;10(1):4. doi: 10.3390/children10010004.

本文引用的文献

1
Long-Term Outcomes in Real Life of Lumacaftor-Ivacaftor Treatment in Adolescents With Cystic Fibrosis.鲁马卡托-依伐卡托治疗青少年囊性纤维化的现实生活长期结局
Front Pediatr. 2021 Nov 15;9:744705. doi: 10.3389/fped.2021.744705. eCollection 2021.
2
Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper.发育药理学的现有知识、挑战与创新:连接儿童专家小组和欧洲发育、围产期和儿科药理学学会白皮书。
Br J Clin Pharmacol. 2022 Dec;88(12):4965-4984. doi: 10.1111/bcp.14958. Epub 2021 Jul 23.
3
Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.
美国和英国囊性纤维化患儿的肺功能:国家注册数据的比较纵向分析。
Thorax. 2022 Feb;77(2):136-142. doi: 10.1136/thoraxjnl-2021-216849. Epub 2021 May 11.
4
Guiding the rational design of patient-centred drug trials in Cystic Fibrosis: A Delphi study.指导以患者为中心的囊性纤维化药物试验的合理设计:一项德尔菲研究。
J Cyst Fibros. 2021 Nov;20(6):986-993. doi: 10.1016/j.jcf.2021.03.021. Epub 2021 Apr 21.
5
Optimising equity of access: how should we allocate slots to the most competitive trials in Cystic Fibrosis (CF)?优化公平性:我们应该如何为囊性纤维化 (CF) 中最具竞争力的试验分配名额?
J Cyst Fibros. 2021 Nov;20(6):978-985. doi: 10.1016/j.jcf.2021.03.027. Epub 2021 Apr 17.
6
Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy.孕期接受CFTR调节剂治疗的母亲所生儿童的正常胰腺功能及新生儿囊性纤维化筛查假阴性结果
J Cyst Fibros. 2021 Sep;20(5):835-836. doi: 10.1016/j.jcf.2021.03.018. Epub 2021 Apr 9.
7
The Clinical Use of Lung MRI in Cystic Fibrosis: What, Now, How?肺 MRI 在囊性纤维化中的临床应用:是什么,现在,怎么做?
Chest. 2021 Jun;159(6):2205-2217. doi: 10.1016/j.chest.2020.12.008. Epub 2020 Dec 17.
8
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial.依伐卡托特在 4 至<12 个月患有囊性纤维化且存在门控突变婴儿中的应用。两项 3 期临床试验的结果。
Am J Respir Crit Care Med. 2021 Mar 1;203(5):585-593. doi: 10.1164/rccm.202008-3177OC.
9
Appearance of Pancreatic Sufficiency and Discontinuation of Pancreatic Enzyme Replacement Therapy in Children with Cystic Fibrosis on Ivacaftor.接受依伐卡托治疗的囊性纤维化患儿胰腺功能充足的表现及胰酶替代疗法的停用
Ann Am Thorac Soc. 2021 Jan;18(1):182-183. doi: 10.1513/AnnalsATS.202006-614RL.
10
Treating Cystic Fibrosis with mRNA and CRISPR.使用 mRNA 和 CRISPR 治疗囊性纤维化。
Hum Gene Ther. 2020 Sep;31(17-18):940-955. doi: 10.1089/hum.2020.137. Epub 2020 Sep 8.